These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

57 related items for PubMed ID: 3186988

  • 1. Superparamagnetic Iron Oxide Particles.
    Gore JC, Majumdar S.
    Radiology; 1988 Dec; 169(3):657-8. PubMed ID: 3186988
    [No Abstract] [Full Text] [Related]

  • 2. The utility of superparamagnetic contrast agents in MRI: theoretical consideration and applications in the cardiovascular system.
    Bjørnerud A, Johansson L.
    NMR Biomed; 2004 Nov; 17(7):465-77. PubMed ID: 15526351
    [Abstract] [Full Text] [Related]

  • 3. Kupffer cell function of hepatocellular adenoma: pulse sequence effects in superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Akatsu T, Ueda M, Shimazu M, Wakabayashi G, Aiura K, Tanabe M, Kawachi S, Tanimoto A, Shinmoto H, Sakamoto M, Kitajima M.
    J Gastroenterol Hepatol; 2004 Aug; 19(8):951-2. PubMed ID: 15242510
    [No Abstract] [Full Text] [Related]

  • 4. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging.
    Stoll G, Bendszus M.
    Neuroscience; 2009 Feb 06; 158(3):1151-60. PubMed ID: 18651996
    [Abstract] [Full Text] [Related]

  • 5. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
    Kubaska S, Sahani DV, Saini S, Hahn PF, Halpern E.
    Clin Radiol; 2001 May 06; 56(5):410-5. PubMed ID: 11384141
    [Abstract] [Full Text] [Related]

  • 6. Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging.
    Weissleder R, Hahn PF, Stark DD, Elizondo G, Saini S, Todd LE, Wittenberg J, Ferrucci JT.
    Radiology; 1988 Nov 06; 169(2):399-403. PubMed ID: 3174987
    [Abstract] [Full Text] [Related]

  • 7. Surface design of core-shell superparamagnetic iron oxide nanoparticles drives record relaxivity values in functional MRI contrast agents.
    Maity D, Zoppellaro G, Sedenkova V, Tucek J, Safarova K, Polakova K, Tomankova K, Diwoky C, Stollberger R, Machala L, Zboril R.
    Chem Commun (Camb); 2012 Dec 04; 48(93):11398-400. PubMed ID: 23066527
    [Abstract] [Full Text] [Related]

  • 8. Quantitation of MR relaxation effects of iron oxide particles in liver and spleen.
    Majumdar S, Zoghbi S, Pope CF, Gore JC.
    Radiology; 1988 Dec 04; 169(3):653-8. PubMed ID: 3186986
    [Abstract] [Full Text] [Related]

  • 9. Efficiently tracking of stem cells in vivo using different kinds of superparamagnetic iron oxide in swine with myocardial infarction.
    Ma GS, Qi CM, Liu NF, Shen CX, Chen Z, Liu XJ, Hu YP, Zhang XL, Teng GJ, Ju SH, Ma M, Tang YL.
    Chin Med J (Engl); 2011 Apr 04; 124(8):1199-204. PubMed ID: 21542996
    [Abstract] [Full Text] [Related]

  • 10. [Usefulness of superparamagnetic iron oxide particles in the detection of hepatocellular carcinoma by MR imaging].
    Hirohashi S, Uchida H, Ohimichi R, Kitano S, Tanaka M, Ohishi H.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Apr 25; 53(4):469-71. PubMed ID: 8388092
    [Abstract] [Full Text] [Related]

  • 11. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver.
    Stark DD, Weissleder R, Elizondo G, Hahn PF, Saini S, Todd LE, Wittenberg J, Ferrucci JT.
    Radiology; 1988 Aug 25; 168(2):297-301. PubMed ID: 3393649
    [Abstract] [Full Text] [Related]

  • 12. Clinical use of contrast media in magnetic resonance imaging.
    Bydder GM.
    Br J Hosp Med; 1990 Feb 25; 43(2):149-52. PubMed ID: 2178714
    [Abstract] [Full Text] [Related]

  • 13. Magnetic resonance relaxation properties of superparamagnetic particles.
    Gossuin Y, Gillis P, Hocq A, Vuong QL, Roch A.
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009 Feb 25; 1(3):299-310. PubMed ID: 20049798
    [Abstract] [Full Text] [Related]

  • 14. [Magnetic resonance tomography of focal liver and spleen lesions. Experiences using ferrite, a new RES-specific MR contrast medium].
    Rummeny E, Weissleder R, Stark DD, Elizondo G, Ferrucci JT.
    Radiologe; 1988 Aug 25; 28(8):380-6. PubMed ID: 3174975
    [Abstract] [Full Text] [Related]

  • 15. Ferrite particles as an MR contrast agent.
    Saini S, Ferrucci JT.
    Radiology; 1988 Dec 25; 169(3):656. PubMed ID: 3186987
    [No Abstract] [Full Text] [Related]

  • 16. Macrophage physiological function after superparamagnetic iron oxide labeling.
    Hsiao JK, Chu HH, Wang YH, Lai CW, Chou PT, Hsieh ST, Wang JL, Liu HM.
    NMR Biomed; 2008 Oct 25; 21(8):820-9. PubMed ID: 18470957
    [Abstract] [Full Text] [Related]

  • 17. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaque.
    Trivedi R, U-King-Im J, Gillard J.
    Circulation; 2003 Nov 11; 108(19):e140; author reply e140. PubMed ID: 14610003
    [No Abstract] [Full Text] [Related]

  • 18. Cardiovascular MR imaging with iron oxide particles: utility of a superparamagnetic contrast agent and the role of diffusion in signal loss.
    Rozenman Y, Zou XM, Kantor HL.
    Radiology; 1990 Jun 11; 175(3):655-9. PubMed ID: 2343109
    [Abstract] [Full Text] [Related]

  • 19. Hot-injection synthesis of iron/iron oxide core/shell nanoparticles for T2 contrast enhancement in magnetic resonance imaging.
    Herman DA, Ferguson P, Cheong S, Hermans IF, Ruck BJ, Allan KM, Prabakar S, Spencer JL, Lendrum CD, Tilley RD.
    Chem Commun (Camb); 2011 Aug 28; 47(32):9221-3. PubMed ID: 21761066
    [Abstract] [Full Text] [Related]

  • 20. Iron oxide MR contrast agents for molecular and cellular imaging.
    Bulte JW, Kraitchman DL.
    NMR Biomed; 2004 Nov 28; 17(7):484-99. PubMed ID: 15526347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.